Loading viewer...
investor_presentation
Format: PDF investor_presentation
Nasdaq: MESO ASX: MSBGlobal Leader in Allogeneic Cellular Medicines for Inflammatory Diseases FY Ended June 30, 2019
presentation
investor_presentation
30 Pages
Shopify
investor_presentation
Roxgold
investor_presentation
Nomura Holdings